Cambridge Research Biochemicals News and Blog

Latest news

5 Nov 2001

CyDye™ – labelled peptides deal with Amersham Biosciences

We are pleased to announce that Cambridge Research Biochemicals Ltd have entered into an exclusive agreement with Amersham Biosciences to synthesise and label peptides with the CyDye™ fluorophores suitable for use in steady state fluorescence, fluorescent polarisation and FRET applications. For more details on the use of CyDye™ fluors in Drug Screening and to request a quotation then please contact your local Amersham Biosciences office or visit their web site at www.amershambiosciences.com